ROANOKE, Va. and FRANKLIN LAKES, N.J., Jan. 22, 2025 /PRNewswire/ — Carilion Clinic, a not-for-profit health care organization serving more than 1 million people in Virginia, in partnership with BD, (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Carilion is the first health system in the state and […]
Tuesday’s release of New Zealand’s consumer price index (CPI) data for the fourth quarter of 2024 showed that underlying inflation continues to soften, aligning with expectations and potentially setting the stage for a rate cut by the Reserve Bank of New Zealand (RBNZ). The reported 0.5% quarter-on-quarter increase in consumer prices matched the forecasts of
NZ inflation data signals RBNZ rate cut likely Read More »
Medtech and drug company’s 2025 sales guidance is below consensus Source link
J&J’s stock surrenders early gains as weak sales guidance offsets earnings beat Read More »
Image source: Getty Images Fortis (TSX:FTS) gave up some of its 2024 gains over the past two months. Investors who missed the rally in the second half of last year are wondering if FTS stock is now undervalued and good to buy for a self-directed Tax-Free Savings Account (TFSA) or Registered Retirement Savings Plan (RRSP)
Is Fortis Stock a Buy Below $62? Read More »
Sign up for daily news updates from CleanTechnica on email. Or follow us on Google News! A ban on fossil advertising in the Hague went into effect in January 2025. The city council approved the ban in September 2024. The Hague is the first city in the world to implement such a ban,
Fossil Fuels Advertising Banned In The Hague, Netherlands Read More »
WARREN, N.J., Jan. 05, 2023 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today announced that it has entered into a license agreement for the development and commercialization of INOpulse® with Baylor BioSciences, a life sciences company dedicated to the
LONDON (Reuters) – Prince Harry settled his lawsuit against Rupert Murdoch’s News Group Newspapers (NGN) over alleged unlawful information gathering, his lawyer said on Wednesday. Harry’s lawyer said a deal had been struck after NGN agreed to pay significant damages and admitted Harry, younger son of Britain’s King Charles, had been the victim of unlawful
Prince Harry wins apology from Rupert Murdoch’s UK papers By Reuters Read More »
Investing.com — Norway’s sovereign wealth fund, managed by Norges Bank Investment Management, has purchased a 25% stake in a portfolio of office and retail properties in London’s upscale Mayfair district. The transaction was valued at approximately £306 million ($378 million). The portfolio includes about 175 buildings situated around Grosvenor Street and Mount Street. The acquisition
Treasury yields drifted lower on Wednesday, continuing to back away as President Donald Trump has yet to impose threatened tariffs. Source link
Treasury yields continue to drift lower Read More »
Dividend aristocrats, those stocks with a long history of consistently increasing dividends, are excellent choices for long-term investing. The reputation for reliability stems from their ability to thrive through economic cycles, showcasing resilience and steady growth. When these stalwarts trade below their highs, it often presents a golden opportunity for investors to secure reliable income
Dividend Seekers: Should You Buy Alaris Equity Stock for its 7.1% Yield? Read More »
